Overview:

The global market for IV bags is projected to reach USD 2.45 billion in 2025, expanding to USD 3.63 billion by 2035, exhibiting a compound annual growth rate (CAGR) of 6.2% during this period. In 2024, the market size was an estimated USD 2.36 billion.

Intravenous drug delivery is a significant application segment, accounting for roughly half of the market. This is attributed to the advantages of rapid drug absorption, precise dosage control, and immediate therapeutic effects, making it essential in hospitals and clinics for administering various medications, including antibiotics, analgesics, and chemotherapy agents.

Demand is also influenced by the increasing prevalence of infections, chronic diseases, and the need for emergency medical services. Furthermore, the rising requirement for IV therapy in home healthcare settings for managing long-term conditions مانند dehydration and infections contributes positively to market growth.

Intravenous therapies represent a dominant application within the IV bag market, holding over 60% share. The growth in this sector is driven by the necessity of IV therapies in treating chronic illnesses, facilitating surgical procedures, and supporting hospital stays.

Conditions requiring intravenous administration for pain management, chemotherapy, or antibiotic treatment are fueling this demand. The increasing adoption of outpatient and home-based healthcare is also boosting the market, extending IV treatment beyond traditional hospital environments. Innovations such as pre-filled IV bags offer added convenience, further stimulating market development.

The IV bag market is poised for substantial expansion over the forecast period, with an estimated incremental opportunity of USD 1280 million, projected to increase the market value by approximately 1.5 times by 2035.

In the initial half of the decade from 2024 to 2034, the industry is forecast to grow at a CAGR of 6.4%, with a slightly lower 5.8% in the latter half. From 2025 to 2035, the first half is anticipated to see a CAGR of 6.9%, while the second half is projected at 5.3%. The market experienced a shift of around 50 basis points in both the first and second halves.

Key growth drivers include the rising demand for IV therapy in various healthcare settings and the increasing trend towards eco-friendly, non-PVC IV bags due to environmental and safety concerns. However, the market faces challenges from stringent regulations and compliance requirements.